Depakote ER is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Divalproex Sodium.
Product ID | 70518-1758_7e8076d1-772d-fe61-e053-2991aa0a6978 |
NDC | 70518-1758 |
Product Type | Human Prescription Drug |
Proprietary Name | Depakote ER |
Generic Name | Divalproex Sodium |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2019-01-01 |
Marketing Category | NDA / NDA |
Application Number | NDA021168 |
Labeler Name | REMEDYREPACK INC. |
Substance Name | DIVALPROEX SODIUM |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021168 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-01-01 |
Ingredient | Strength |
---|---|
DIVALPROEX SODIUM | 250 mg/1 |
SPL SET ID: | 3a7ec88a-3379-4376-b49a-f60ae8b09fd0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
70518-1758 | Depakote ER | Depakote ER |
70518-1759 | Depakote ER | Depakote ER |
43353-310 | Depakote ER | Depakote ER |
63629-3370 | Depakote ER | Depakote ER |
0074-3826 | Depakote | Divalproex Sodium |
0074-6114 | Depakote | Divalproex Sodium |
0074-6212 | Depakote | Divalproex Sodium |
0074-6214 | Depakote | Divalproex Sodium |
0074-6215 | Depakote | Divalproex Sodium |
0074-7126 | Depakote | Divalproex Sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DEPAKOTE 75295484 2197507 Dead/Cancelled |
SANOFI-AVENTIS 1997-05-21 |
DEPAKOTE 73383028 1377834 Live/Registered |
SANOFI 1982-09-01 |